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With the advent of powerful computers and magnetic resonance imaging (MRI) scanners, a 
novel diagnostic and prognostic approach in medicine developed recently that uses computer-
based regression algorithms evaluating brain MRI signals for disease prediction. In this 
approach, a regression algorithm typically first extracts certain regularities related to a criterion 
of interest (e.g. the presence or severity of a disease) from exemplary MRI data and then 
evaluates MRI data of unknown subjects with regard to this criterion based on the extracted 
regularities. The approach is currently very popular as it promises to enable automated diagnosis 
of disease and to aid in the early detection of disorders and in prognosis of treatment responses. 
Consistent with the expected utility of the approach, it yielded hundreds of publications and is 
used for neurologic, psychiatric and metabolic disorders (see Sundermann et al., 2014; Cohen et 
al., 2011; Bray et al., 2009; Demicri et al., 2008 for an overview). In this synopsis, I will describe 
the basic concept of the approach, its development, and research aims pursued with it in the 
Introduction. In the second part, I will describe the articles that I submit for habilitation in terms 
of the concepts and methods delineated in the Introduction.  
 
1.1 Basic concept 
Although a variety of slightly different methods are used in the framework of the proposed 
approach, the majority of these methods are regression techniques used in a model-validation 
framework. In the literature, this combination of regression and model-validation is frequently 
referred to as multivariate pattern analysis (MVPA; see Sundermann et al., 2014; Cohen et al., 
2011; Bray et al., 2009; Pereira et al. 2009; Demicri et al., 2008; Haynes et al., 2006; Norman et 
al., 2006 for an overview). Algorithms used in MVPA can be subdivided into algorithms for 
nominal regression (usually referred to as ‘classifiers’) and algorithms for continuous regression. 
Please note that I use the term ‘regression’ synonymously for binary and continuous regression 
in the following due to this technical relationship of 'classification' and 'regression'. Furthermore, 
the use of MVPA techniques for data analysis can be described with a three-step scheme 
comprising Feature determination, Training and Test. In short, a set of features relevant for an 
investigated disorder is selected from or computed based on all available MRI features in the 
feature determination stage. After the features have been determined, the corresponding signals 
are sampled across all available subjects and are combined in subject-specific feature patterns. In 
the training stage, patterns of a subset of subjects (i.e. the training subjects) are used to determine 
a regression function characterizing the regularities in the training patterns with regard to a 
criterion of interest. In the test stage, MRI feature patterns of novel subjects (i.e. the test subjects) 
are evaluated with regard to this criterion based on the regularities extracted in the training stage. 
In the following, the three stages are described in more detail. 
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1.1.1 Feature determination  
In this stage, explanatory MRI features (e.g. blood flow or cortical thickness at specific 
coordinates) must be selected from or computed based on all available raw MRI variables 
(typically MRI signals measured in small cuboid-shaped spatial measurement units called 
voxels) that are considered relevant for a given research question. After the features have been 
determined, the corresponding signals from these features are sampled across all subjects and 
combined in subject-specific feature patterns. In the literature, various feature determination 
methods are used.  
The simplest way is to directly use the MRI signals contained in all available voxels as 
features (i.e. to use a ‘whole brain’ approach as e.g. in Fu et al., 2008; Zhang et al., 2005). 
However, although the method is easy to implement it has also two important drawbacks. First, it 
is typically associated with a poor multivariate signal-to-noise ratio (SNR) as dysregulation of 
functional processes in psychiatric or neuropathology in neurologic disease is typically not 
uniformly distributed across the brain and the approach thus tends to include a large number of 
disorder-irrelevant features. Second, redundancy or collinearity among features can become a 
problem in the whole brain approach. Specifically, since the number of unknowns (i.e. MRI 
features; usually several thousand) exceeds the number of equations in this approach (i.e. 
training subjects; usually several dozens), determination of a regression function can (depending 
on the regression algorithm) correspond to solving an underdetermined set of equations from a 
mathematical perspective. In underdetermined equation systems, any unknown can be expressed 
as a linear combination of a subset of other unknowns from the same system as soon as the 
number of unknowns in the subset equals the number of equations. Correspondingly, 
underdetermined equation systems are highly redundant what can in turn lead to unstable 
estimates for regression coefficients in linear multiple regression meaning that already tiny 
variations in the features can induce large changes in the regression coefficient estimates. Thus, 
especially the choice of the regression algorithm has to be handled with care in a whole brain 
approach (see Dormann et al., 2013 for an overview). 
To address these issues, ‘region of interest’ (ROI) approaches are frequently applied for 
feature selection. In this approach, MRI signals are only drawn from voxels located in 
functionally relevant networks in psychiatric research (e.g., Weygandt et al., 2012) or located in 
regions with a relevant tissue type (grey or white matter) in neurologic research (e.g., Weygandt 
et al., 2015a; Lee et al., 2014; Bendfeldt et al. 2012; Klöppel et al., 2008a, b). Alternatively, ROI 
are used for pattern generation by computing single aggregate measures across a whole ROI such 
as the hippocampal volume in Alzheimer’s Disorder (AD) that are then integrated into patterns 
consisting of several of such features (Ritter et al., 2015; Cuingnet et al., 2011). Finally, in a 
specific variant of the ROI approach (that might also be considered as a mixture of the whole-
brain and the ROI approach) known as searchlight method (Haynes et al., 2007; Kriegeskorte et 
al., 2006), disease-related MRI signals are selected from voxels in small spherical areas 
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surrounding a center voxel (Hackmack et al., 2012a; Weygandt et al., 2012) and regression 
models and prediction accuracy measures are then computed for these local patterns. This local 
regression procedure is repeated until each voxel included in a given analysis has been used once 
as center of a searchlight. Consequently, the method allows searching for informative areas 
regarding a given disorder across the whole brain by exploiting local multivariate imprints of 
functional dysregulation or neuropathology while circumventing the poor signal-to-noise 
problem of the whole-brain approach. 
Component-based methods such as independent (ICA) or principal component analysis 
(PCA) correspond to another group of feature determination methods that can be applied to 
address the problems of the whole-brain approach. In particular, these methods identify 
directions (i.e., components) in voxel space that are either mutually orthogonal (PCA) or 
stochastically independent (ICA). Please see Stone (2001) for a comparative overview on these 
methods. After these directions have been identified, voxel information is projected onto them 
and the resulting component loadings are used as feature patterns for a subject (Wilette et al. 
2014; Kawasaki et al. 2007; Ford et al., 2003). 
Finally, methods frequently used in computer vision such as such as Scale Invariant 
Feature Transformation (Chen et al., 2014), Wavelet Analysis (Hackmack et al., 2012b), or 
Texture Analysis (Zhang et al., 2008) can be considered as another larger (but heterogeneous) 
group of feature determination methods. Consistently, these methods compute higher-level 
image (here: volume) statistics such as edges and spatial intensity contrasts that can then be 
combined in feature patterns handed over to a regression algorithm for training and testing. 
 
1.1.2 Training  
In this stage, a regression algorithm determines a mathematical regression function that maps the 
feature patterns onto a criterion vector following a statistical optimization procedure specific for 
the algorithm. Importantly, only patterns of a subset of subjects (i.e. of the training subjects) are 
used in this mapping procedure. Depending on the application (i.e. diagnosis of medical status or 
prediction of disease severity), the criterion vector can either code the group membership (e.g., 
diseased or healthy; Weygandt et al., 2015a; 2012) or symptom scores of training subjects as 
e.g., assessed by the Expanded Disability Status Score (EDSS; Kurtzke, 1983) in multiple 
sclerosis (MS; Hackmack et al., 2012a) or the Mini-Mental Status Examination (Folstein et al., 
1975) in AD (Stonnington et al., 2010). To achieve the mapping, a large variety of regression 
algorithms has been used in the computerized MRI disease prediction framework. For example 
Canonical Correlation Analysis (CCA; Hackmack et al., 2012a), Linear Discriminant Analysis or 
Multivariate Analysis of Variance (MANOVA; Allefeld & Haynes, 2014) respectively, Logistic 
Regression (Weygandt et al., 2015a), Partial Least Square Regression (Chen et al., 2010), 
Support Vector Classifiers (SVC; Weygandt et al., 2012; Fu et al., 2008; Klöppel et al., 2008a, b) 
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and Support Vector Regression (Stonnington et al., 2010) to name just a few. Each of these 
regression algorithms is characterized by a specific optimization method. For example, SVC try 
to find a direction in feature space that maximizes the distance between patterns located in the 
transition area between classes, i.e. to find a large-margin that separates the classes (c.f., Müller 
et al., 2001). Alternatively, MANOVA identifies the direction(s) in space with the maximal ratio 
between inter-group and intra-group variation (Allefeld & Haynes, 2014). For a detailed 
overview on methodological aspects of a variety of MVPA algorithms, please see Duda et al. 
(2000).  
 
1.1.3 Test  
In the test stage, the mathematical regression model determined during training is used to 
evaluate patterns of novel subjects not used for model determination (i.e. of the test subjects) 
with regard to the criterion of interest. After this has been done for each available test pattern,  
accuracy measures are computed such as the percentage of correctly classified patterns, the mean 
of sensitivity and specificity, or the multiple correlation coefficient to name a few. Then, 
measures of inferential statistics are computed for these accuracy parameters e.g., by permutation 
testing (Good, 2005). In short, in permutation testing the true criterion vector is permuted several 
times and the classification procedure (i.e. training and testing including accuracy determination) 
is conducted for each of the permutations separately which finally yields a distribution of 
permutation accuracies. After this distribution has been determined, it is used to assess the 
probability of the empirically observed accuracy in terms of the relative proportion of 
permutation accuracies having minimally the extent of the empirical accuracy. Please see e.g., 
Weygandt et al. (2015a) for details of permutation testing in an MRI disease prediction 
framework. 
 
1.2 Development of the method  
The development of the approach from its beginning to now can probably be described best in 
terms of three epochs characterized by the discovery of diagnostic information in MR signals, 
the first use of statistical regression techniques to analyze this information, and finally the mass 
use of the approach. 
 
1.2.1 Discovery of diagnostically relevant information in MR signals 
In particular, the pivotal study of Raymond Damadian in the early 1970s ‘Tumor Detection by 
Nuclear Magnetic Resonance‘ (Damadian, 1971) might be considered as the starting point of this 
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development. In this study, Damadian used nuclear magnetic resonance (NMR) measurements to 
discriminate between healthy and cancerous tissue in rats based on differences of 1H NMR 
relaxation times and thus showed for the first time that MR properties of biological entities can 
contain diagnostically exploitable information.  
 
1.2.2 First analyses of diagnostic information with computer-based regression  
After this first conceptual step, a small series of neurological studies evolved in the 1990s that 
started to analyze brain MRI scans with MVPA techniques for disease classification in a second 
stage. In particular, Namer and colleagues (Namer et al., 1993) used MVPA techniques and 
MRI-derived biomarkers to separate MS patients from patients showing high-risk factors of 
cerebrovascular diseases but no focal neurological symptoms. The study revealed high sensitivity 
of the computer-based diagnostic approach being approximately 20% superior to that achieved 
by human experts using MRI criteria existing at that time (Fazekas et al., 1988). Importantly, 
high diagnostic accuracy of the computer-based approach in this early work was already 
achieved in a model-validation framework, i.e. by applying a regression model derived from a 
set of training subjects to an independent set of test subjects. Inspired by this work, Barkhof and 
colleagues (Barkhof et al., 1997) used multivariate regression techniques to compare existing 
MRI criteria for future conversion from clinically-isolated syndrome (CIS) to clinically definite 
MS or more precisely they used the method to select an optimal set of MRI criteria for diagnosis 
performed by neurologists. Similar to the results obtained by Namer et al. (1993), results of this 
study (Barkhof et al., 1997) showed that the optimal set of features identified by MVPA was 
superior to feature sets suggested in diagnostic criteria existing at that time (Fazekas et al., 1988; 
Paty et al., 1988). Finally, the first study that used functional MRI (fMRI) for classification of 
neurologic patients originated in the early 2000s. In particular, Ford et al. (2003) evaluated brain 
activity acquired with fMRI during a word generation task to separate between elderly patients 
diagnosed with early AD and healthy control (HC) subjects of comparable age with MVPA 
including model-validation techniques.  
 In psychiatric research, computer-based patient classification using MRI signals was first 
performed in the early 2000s. In particular, Ford et al. (2002) used MRI-based MVPA including 
model-validation techniques to separate 15 schizophrenic patients from 8 HC subjects based on 
hippocampal MRI signals. The authors achieved good diagnostic accuracy although it is unclear 
whether the unequal group sizes might have biased the results because the authors exclusively 
reported the percentage of correctly classified patterns instead of measures correcting for unequal 
group sizes (e.g., the mean of sensitivity and specificity). Furthermore, it has to be mentioned 
that an MVPA neuroimaging approach for classification of schizophrenic patients (versus HC 
subjects) was already applied in 2001 by Meyer-Lindenberg and colleagues (Meyer-Lindenberg 
et al., 2001) in a Positron Emission Tomography (PET) study. In particular, the authors evaluated 
PET connectivity patterns during a working memory task to separate between patients and 
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controls. Importantly, they also used model-validation techniques as described for Namer et al. 
(1993). Unfortunately, the results of the model-validation analysis are hard to interpret in terms 
of a diagnostic approach since multiple patterns of individual subjects entered the analysis and 
the authors only report overall pattern separability and not separability of patterns specific for 
individual subjects.  
  
1.2.3 Mass use of the computerized MRI disease prediction approach 
Inferred from the distribution of publication dates reported for computer-based MRI disease 
prediction studies in review papers (e.g., Sundermann et al., 2014; Cohen et al., 2011; Bray et al., 
2009; Demicri et al., 2008), a third epoch in the development of the approach characterized by its 
mass use started approximately in 2008 and lasts until now. This time point is also consistent 
with the publication of the most cited research article from the field by Klöppel et al. (2008a) 
with currently more than 500 citations (according to Google Scholar). During this third stage, the 
approach has been applied to a vast number of neurological disorders, e.g., in AD (Ritter et al., 
2015; Dukart et al., 2013; McEvoy et al., 2009), MS (Weygandt et al., 2015a; Bendfeldt et al., 
2012), Parkinson’s Disease (Long et al. 2012), and stroke (Saur et al., 2010). In psychiatric 
research, the approach has been used in attention deficit hyperactivity disorder (Bohland et al., 
2012), autism (Anderson et al., 2011), depression (Hahn et al., 2011), eating disorders 
(Weygandt et al. 2012), obsessive-compulsive disorder (OCD; e.g., Hoexter et al., 2013), 
pedophilia (Ponseti et al., 2012) and schizophrenia (Zarogianni et al., 2013). Please note, that 
these studies are mentioned here exclusively  to give a small impression on the range of disorders 
the approach has been applied to and is far from being complete.  
 
1.3 Research aims 
Besides characterizing studies in the field based on different developmental stages or 
investigated disease domains, they can also be categorized based on the research aims pursued 
with the computer- and MRI-based disease prediction approach. Reviewing the literature shows 
that computer- and MRI-based disease prediction is (considered to be) applied in three 
frameworks. First, in an automated diagnosis setting. Second, to refine existing diagnostic 
criteria for diagnosis performed by human medical experts. Finally, the approach is used to 
identify novel diagnostic biomarkers. Please note that these goals are not mutually exclusive, i.e. 





1.3.1 Automated diagnosis 
When a computerized patient classification system based on MRI signals is (intended to be) used 
in an automated diagnosis framework, it is expected to diagnose the unknown clinical status of a 
subject blindly i.e., without further human assistance exclusively based on a given set of MRI 
signals. Furthermore, such a system should reach very high diagnostic accuracy that is optimally 
superior to that obtained by human diagnosticians. Finally, such an approach should achieve 
constant diagnostic accuracy independent of e.g., differences in radiological expertise across 
medical experts. That this is possible could at least in part be shown in a study by Klöppel et al. 
(2008b). In this study, the authors compared the performance of a computer-based system in 
diagnosing AD with that of physicians having two different levels of expertise in this diagnostic 
task, i.e. general radiologists who evaluated brain scans during less than 5% of their daily work 
time and neuroradiologists who performed this task during more than 40%. The results showed 
that the computer-based approach and neuroradiologists both achieved very high (and 
comparable) accuracies in separating patients and HC subjects whereas overall radiologists only 
achieved moderate diagnostic accuracies.    
Despite the promising character of such results suggesting a potential role of computer- 
and MRI-based diagnosis in clinical practice, several difficulties have to be coped with in a real-
world application that do not apply in a research setting like in Klöppel et al. (2008b). In 
particular, (data of) Alzheimer’s patients fulfilled a variety of well-defined research criteria e.g. 
the AD diagnoses were confirmed histopathologically (c.f. McKhann et al., 1984) in this study. 
Furthermore, patients were controlled for covariates such as having no family history of AD. 
Consequently, MVPA algorithms could extract / apply classification rules from / to very well-
defined and prototypical data. In a real-world setting however, the majority of test data would 
presumably be less prototypically as e.g. Schneider et al., (2009) could show that patients 
suffering from AD frequently have a mixed neuropathology, i.e. they have features characteristic 
for AD but also features characteristic for vascular dementia such as cerebral infarcts. Due to 
such overlaps, diagnostic accuracies obtained by the computer-based approach in a research 
setting as in the study of Klöppel et al. (2008b) could overestimate accuracies obtainable in a 
real-world clinical setting to an unknown extent. Thus, in addition to substantial infrastructural 
demands, handling of missing data, and further aspects this problem might be an important 
reason for the fact that the approach is only used in research and not in an applied clinical routine 
framework until now. However, despite these issues there are currently several research projects 
such as the ‘iDSS - Integrative Decision Support System for diagnosis of dementia in hospitalized 
elderly patients’ from the Bernstein Center for Computational Neuroscience Berlin and other 
groups (e.g., Ritter et al., 2015) or ‘PredictAD’1 that aim to solve these problems and to establish 
the approach in a clinical real-world setting.  
                                                          
1 See http://geriatrie.charite.de/en/research/research_projects_of_the_working_group_age_ 
technology/idss/ and www.predictad.eu for further information 
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1.3.2 Refinement of diagnostic guidelines  
Furthermore, the approach is also used to refine existing diagnostic guidelines for human 
diagnosticians. For example, Barkhof et al., (1997) used it to select an optimal set of MRI criteria 
for prognosis of future conversion from CIS to clinically definite MS. Specifically, they first 
pooled continuously scaled MRI features included in various diagnostic guidelines existing for 
this task at the time of the study (e.g. the number of periventricular hyperintense lesions in T2-
weighted MR images; Fazekas et al., 1988; Paty et al., 1988) and then used varying cut-off 
scores to dichotomize the continuous feature scores into present and absent. After 
dichotomization, all cut-off dependent variants of all features were handed over to a Logistic 
Regression algorithm. Specifically, they used a stepwise regression approach to identify a set of 
non-redundant MRI criteria and corresponding cut-off scores that was superior to the (sets 
included in the) initial guidelines (Fazekas et al., 1988; Paty et al., 1988). They found that a four-
parameter model including periventricular, infratentorial, and juxtacortical lesions together with 
gadolinium-enhancement best predicts conversion from CIS to MS. Thus, by using this 
approach, they provided easy to use diagnostic guidelines for daily routine in clinical hospitals.  
 In another attempt to use the approach for refinement of diagnostic guidelines, I used it to 
clarify whether it is possible to separate between subjects suffering from Bulimia Nervosa (BN) 
and subjects suffering from so called Binge-Eating Disorder (BED; Weygandt et al., 2012; see 
2.1 for details). The question is important, since it was unclear for a long time whether BED 
should be considered as an autonomous diagnostic category or as a variant of BN because BN 
and BED share important commonalities on the phenomenological level (e.g., bingeing, 
comparable levels of body dissatisfaction and fear of weight gain). Consequently, BED was 
included as a provisional diagnostic category in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM), edition IV (American Psychiatric Association, 1994) only.  
 
1.3.3 Identification of novel diagnostic and prognostic biomarkers 
Finally, MRI and computer-based regression are used to search for novel diagnostic biomarkers 
in a wide range of medical disorders. For example, I used the method to search for non-lesion 
related markers of MS in MRI images measured with standard MRI-sequences (Weygandt et al., 
2015a). Van den Bogaard et al. (2012) / Kidwell et al. (2013) give an overview on the use of 
these techniques for identification of biomarkers in Huntington’s Disease / stroke. In psychiatric 
research, I used the technique to identify novel diagnostic biomarkers for Eating Disorders 
(Weygandt et al., 2012). Hahn et al. (2011), McGrath et al. (2013), Pizzagalli (2011) and Fu et 
al. (2008) describe neuroimaging-derived biomarkers for depression. Furthermore, Zarogianni et 
al. (2013) give an overview on the use of SVC for identification of MRI-derived biomarkers in 
Schizophrenia. Finally, I used MRI and computer-based regression in the domain of metabolic 
11 
 
disorders, i.e. to search for prognostic biomarkers of short- (Weygandt et al., 2013) and long-
term dietary success in obesity (Weygandt et al., 2015b).   
At this point, it is important to mention that although it might appear that only 
classification techniques used in a model-validation framework can be used to search for 
diagnostic biomarkers due to their subject- or exemplar-oriented perspective also traditional 
methods such as t-tests can be used for this purpose. In order to understand this, one might 
consider a single hypothetical MRI feature measured for an arbitrary patient and a control group 
characterized by a high (absolute) t-statistic. Given the definition of the t-statistic in a two-
sample t-test for independent samples with unequal variance:    











mmt   
with m1/2 being the group means, s1/2 the standard deviations, and n1/2 the group sizes, this feature 
would also enable high diagnostic separability of subjects because the group means would be 
localized fairly apart from each other and the signal value of each specific group member would 
be quite close to the mean signal of its group. Under these circumstances, a simple hypothetical 
classifier not using model-validation that classifies subjects into groups based on the minimal 
Euclidean distance to the respective group means would also obtain high diagnostic accuracy. 
Consequently, unless no model-validation I used it is quite obvious that accuracy obtained by 
classifiers on one hand and t-statistics computed by t-tests on the other are highly related.  
However, given that classification procedures typically involve a model-validation step, 
one might ask what the relation of classification accuracy obtained in a validation framework and 
t-scores not computed in such a framework is. To understand this, techniques of model-
validation frequently used in classification such as the leave-one-out (LOO) cross-validation 
(CV) strategy have to be considered (for an overview on CV see e.g., Duda et al. [2000]). In 
LOO CV, only one pattern is removed from the set of all available patterns in a single CV 
iteration and is used for testing, the remaining patterns are used as training patterns. This 
procedure is repeated until all patterns were once treated as test pattern and a measure of 
accuracy is computed that summarize diagnostic separability of test patterns / individual subjects 
belonging to the different groups. When keeping this procedure in mind, it becomes clear that 
LOO CV does not change that relation dramatically since when only one pattern is removed 
from all available patterns during division into training and test, the statistical properties relevant 
for classification in each LOO iteration (here: group means and intra-group signal variations) 
would be more or less identical to these properties obtained for the full set of patterns. 
Consequently, one can conclude that the test statistics obtained by classifiers using certain 
common model-validation techniques (i.e. 'leave-few-samples-out' CV) and by more traditional 
procedures such as t-tests not using model-validation are highly related because also the relation 
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of underlying statistical properties is strong. Importantly, the same applies for the link of 
multivariate classification with CV and traditional multivariate statistics without CV (e.g. 
Hotellings T2 for independent samples) as well as for uni- and multivariate continuous regression 
with and without CV. This can be seen in Figure 1 that summarizes the results of corresponding 
simulation analyses.  
 
Figure 1. Relation between statistical parameters obtained by combining regression and model-validation 
techniques on one hand and parameters used in traditional analyses not using model-validation on the 
other for simulated data. In particular, the upper panel depicts this relation for binary regression (i.e. 
classification) with cross-validation (CV) and different t-tests without CV. Specifically, the left graph 
shows the link between the absolute Student t-statistic computed for 1000 single random variables (n = 
20) drawn from a standard normal distribution and classification accuracy obtained for the same data with 
a univariate Logistic Regression classifier in a CV framework. In each of the 1000 variables, ten data 
points (i.e., ‘subjects’ or ‘exemplars’) corresponded to a hypothetical group A and ten corresponded to a 
hypothetical group B. In order to compute ‘diagnostic’ accuracy, a balanced leave-two-out CV approach 
was used, i.e. one exemplar from group A and one from group B in each iteration during the CV 
procedure was excluded from training and used for testing instead. To determine a simple measure of the 
association between absolute Student t-statistics and diagnostic accuracies, I computed the Pearson 
correlation coefficient that assesses the linear link between two variables. Across all 1000 variables this 
revealed a correlation of r = 0.76 and thus a strong (Cohen, 1988) linear dependency. The upper right 
13 
 
graph depicts the link of Hotellings T2 for independent samples computed for 1000 multivariate feature 
sets consisting of 3 random variables drawn form a standard normal distribution on one hand and the 
‘diagnostic’ accuracy obtained for the same data with a multivariate Logistic Regression classifier in a 
cross-validation framework on the other. As for the univariate case, ten data points in each of the feature 
sets correspond to a hypothetical group A and ten correspond to a hypothetical group B. Hotellings T2 for 
independent samples can be considered as the multivariate counterpart of the Student t-statistic and is 











3 . In this equation, ∆M corresponds to a row 
vector containing the mean difference of each feature between the two groups, CovA and CovB correspond 
to the covariance matrices of the three features in group A and B, and nA and nB correspond to the group 
size of each of the groups. The CV method used was the same as described for the univariate case. The 
Pearson correlation coefficient computed between Hotellings T2 and diagnostic accuracies across all 1000 
features sets was r = 0.74 and was thus almost identical as for the univariate data set. In the lower panel, 
the relation between uni- (left graph) and multivariate (righ graph) continuous regression with and 
without model-validation is depicted. In particular, the left graph depicts the relation between correlation 
coefficients between true and predicted criterion vectors computed with linear regression based on a 
single predictor (plus constant) and a criterion vector in a leave-two-out CV framework and correlation 
coefficients between true and predicted criterion vectors computed without CV. Please note, that the latter 
technique (one predictor of interest, one constant predictor, one criterion, no CV) is sometimes also 
referred to as 'simple regression'. Again, this relation was computed for 1000 random predictor variables 
and a single random criterion (n = 20) that were all drawn from a standard normal distribution. The 
Pearson correlation between (Fisher-Z transformed) correlations computed with and without CV was r = 
0.86, indicating a quite strong linear dependency. The right graph depicts the same association except for 
the fact that the random criterion was now predicted based on multivariate feature sets containing three 
random predictors (plus constant). For the multivariate case, the relation between (Fisher-Z transformed) 
correlations computed with and without CV was very similar to that computed with a univariate model, 
i.e. r = 0.92.   
 
Thus, when integrating these considerations and results one can conclude that just as MVPA and 
CV, traditional mass univariate analysis techniques (c.f., Kiebel & Friston, 2004) without CV 
(e.g., t-tests [Hölzel et al., 2008] and simple regression [Weygandt et al., 2015b; 2013]) can be 
used to search for diagnostic and prognostic biomarkers. However, despite a similar utility of 
these methods in this specific aspect, MVPA and CV are obviously better suited for applied 
automated diagnosis and for refinement of diagnostic guidelines as they are directly addressing 






2 Description of submitted articles  
2.1 Diagnosing different binge-eating disorders based on reward-related brain 
activity patterns 
In this fMRI picture perception study (Weygandt et al., 2012), we investigated how visual food 
cues are encoded in areas of the reward and incentive salience systems in eating disordered 
patients (bulimia nervosa [BN; n = 14] and binge-eating disorder [BED; n = 17]) and control 
subjects (overweight to obese, n = 17; normal weight, n = 19). Furthermore, we tested whether 
classifiers can utilize differences in food cue-elicited brain activity patterns in reward- and 
motivation-related areas to separate between individual BN and BED patients. This question is 
important, since it was long unclear whether BED is an autonomous diagnostic category or a 
variant of BN because BN and BED share important commonalities on the level clinical 
symptoms (e.g., bingeing, comparable levels of body dissatisfaction and fear of weight gain). 
Consistently, BED was included in the DSM-IV (American Psychiatric Association, 1994) as a 
provisional diagnostic category only. Inspired by this ambiguity, the study aimed to clarify 
whether existing diagnostic criteria of eating disorders can be refined by the application of MRI- 
and computer-based patient classification. 
 To address both questions, we used an SVC algorithm in two slightly different 
searchlight decoding frameworks and conducted two pattern recognition analyses. In the first 
analysis, we searched for brain regions in a large ROI comprising areas of the reward and the 
incentive salience systems (i.e. the amygdala, anterior cingulate cortex, insula, lateral and medial 
OFC, and the ventral striatum) that separate between high calorie food and neutral control 
pictures based on local searchlight fMRI activation patterns within groups. For this aim, a leave-
two-out CV approach was used. In particular, in each CV iteration a SVC classifier was trained 
with the searchlight patterns of voxel regression coefficients reflecting the local responsivity to 
high-calorie pictures and with patterns of voxel regression coefficients for control pictures of all 
but one subject of a given group. These voxel-wise regression coefficients for both picture 
categories were computed in a traditional first-level within-subject analysis using linear 
regression / a general linear model in advance to the pattern recognition analysis. In the test 
stage, the given searchlight classifier was used to predict the picture categories (food vs. neutral) 
of both searchlight regression coefficient patterns of the left out subject.  
In the second pattern recognition analysis, we used a searchlight ensemble approach and 
a nested CV procedure to test whether eating disordered patients (BED and BN) can be separated 
based on searchlight voxel contrast parameters assessing the difference between voxel regression 
coefficients for high-calorie minus neutral pictures. In the nested CV approach, a second-level 
LOO CV loop was conducted based on the training data of (i.e. ‘inside’) the first-level LOO CV 
loop as multivariate features selection method. In particular, after diagnostic accuracy for patient 
separation of both groups was determined for all searchlights in the second-level loop (i.e. based 
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on the patterns of all but one subject), the five best performing searchlight classifiers were 
selected as members for a searchlight ensemble classifier. These five local classifiers were then 
retrained with all training data of the first-level LOO CV loop and used to predict the class of the 
patient left out as test subject in the first level LOO CV loop. Finally, the average decision across 
classifiers in the ensemble was used for diagnosis. This ensemble decoding approach was 
performed for each of the subregions included in our reward and salience ROI separately (i.e., 
for amygdala, anterior cingulate cortex, etc.).  
In the first pattern recognition analysis investigating the encoding of visual food cues, 
significant accuracy for separation of food and control stimuli was possible in the insula in all 
groups. This finding is in line with the fact that the insula contains the primary gustatory cortex 
(Augustine, 1996) and could thus be understood as a basic brain response pattern to food cues 
reflecting gustatory properties of nourishment. Importantly however, stimulus separation in areas 
belonging to the dopaminergic reward system (ventral striatum) and the incentive salience 
network (anterior cingulate cortex and amygdala) that are related to addiction-like phenomena 
such as craving (Pelchat et a, 2009) was only possible in eating disordered patients. In the second 
analysis investigating the differential diagnosis of BED vs. BN, significant classification 
accuracy was obtained in the anterior cingulate cortex, insular cortex and ventral striatum. 
Interestingly, patterns separating between individuals of the different eating disorders were 
consistently characterized by slightly higher activation in BN what might indicate a stronger cue-
elicited urge to consume food or stronger food craving respectively in BN. 
Taken together, our finding of BED and BN separability based on reward/motivation-
related fMRI activation patterns fits well to the inclusion of BED as an autonomous eating 
disorder in the current edition of the DSM-V (American Psychiatric Association, 2013). 
Furthermore, the results suggest that the computer- and MRI-based approach for patient 
classification can contribute to the refinement of existing diagnostic guidelines for psychiatric 
disorders.    
 
2.2 Role of neural impulse control mechanisms for dietary success in obesity  
Here (Weygandt et al., 2013), we investigated whether neurobehavioral correlates of control in 
reward-related decision-making, a concept closely connected to a key criterion in substance 
dependence (considered as psychiatric disorder in the ICD), i.e. loss of control over begin and 
end of substance consumption, contains prognostic information for dietary success in obesity. 
Importantly, obesity is considered as a metabolic disorder in the ICD. 
 Influential neuroscientific studies on decision-making (e.g., Hare et al., 2011; 2009) 
propose that behavioural control in reward-related decision-making strongly depends on a 
modulatory influence of the dorsolatelral prefrontal cortex (DLPFC) on ventromedial prefrontal 
cortex (VMPFC). In particular, in Hare et al. (2009) self-reported dieters had to select repeatedly 
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between two food items, a constant reference item with average taste- and health-related 
properties determined for each subject individually and another food item that varied in terms of 
taste- and health-related aspects. The study revealed several interesting findings. First, it showed 
that VMPFC activity reflected the subjective value of / relative preference for food items 
independent of taste and healthiness of a given item (i.e. independent of how much control was 
necessary to prefer the item). Second, activity in the DLPFC was positively linked to successful 
self-control (i.e. showed higher activity when subjects chose an item that was healthier and less 
tasty than the reference item). Finally, VMPFC and DLPFC activity showed significant 
correlation during successful control trials only. From these findings, the authors concluded that 
the VMPFC computes a value-signal (which might also be considered as a "liking" signal in 
terms of the motivation/addiction literature; e.g. Volkow et al., 2002) that integrates control-
related aspects of cued reinforcers computed in the DPLFC (health) and rewarding properties of 
these stimuli (taste).   
 To investigate the relevance of such processes for success of obese patients (n = 16) in a 
12-week diet, we conducted an fMRI study measuring food-specific delay discounting at 
baseline and used neural and behavioral parameters derived thereof to predict dietary success 
across the 12-week interval. Dietary success was assessed as body-mass index [BMI] at the 
beginning of the diet minus BMI at the end of the diet, corrected for several covariates-of-no-
interest (see Weygandt et al., 2013 for details regarding the covariates correction procedure). In 
the food-specific delay discounting task conducted directly before the beginning of the diet, 
subjects had to choose between an immediately gratified but small portion of a preferred meal 
and a larger portion of the meal gratified with a certain time delay. 
We found a) a negative correlation of food-related impulsivity and dietary success, and b) 
value-based VMPFC and DLPFC activity with a significant positive correlation to dietary 
success. c) Diet-predictive DLPFC activity was negatively linked to impulsivity of food choices. 
Furthermore, d) connectivity between VMPFC and DLPFC was positively linked to dietary 






Figure 2. Neural impulse control mechanisms and their relation to dietary success in obesity. a) Control-
related brain activity with prognostic information for dietary weight loss. Brain area abbreviations 
highlight regions with above chance correlations between control-related activity and weight loss as 
determined by permutation testing. Coordinates reported were significant on a threshold corrected for 
multiple testing with the False-Discovery-Rate method (αFDR = 0.025). Numbers beneath abbreviations 
correspond to Pearson correlation coefficients obtained in these areas. Indices beneath each coronar brain 
slice report the y-coordinate of this slice in the standard space of the Montreal Neurological Institute 
(MNI) brain template (Tzourio-Mazoyer et al., 2002). b) Functional connectivity of the VMPFC with 
prognostic information for dietary weight loss. Prognostic information was determined based on voxel 
parameters characterizing the connectivity of a given voxel with the VMPFC voxel depicted in (2a, i.e. 
for MNI: -6, 48, -9). Brain area abbreviations highlight regions with above chance (αFDR = 0.025) 
correlations between connectivity and weight loss as determined by permutation testing. Numbers 
beneath abbreviations correspond to Pearson correlation coefficients obtained in these areas. Indices 
beneath each transversal brain slice report the z-coordinate of this slice in the standard space of the MNI 
brain template. Slices in a and b are displayed in neurological orientation. Brain area abbreviations: 
AINS, anterior insula; DST, dorsal striatum; DLPFC, dorsolateral prefrontal cortex; DMPFC, 
dorsomedial prefrontal cortex; VMPFC, ventromedial prefrontal cortex. Graph and caption of the figure 
are adapted from Weygandt et al. (2013). 
 
Taken together, the results of our study nicely complement the findings of Hare et al. 
(2009) by showing that DLPFC brain activity and VMPFC - DLPFC connectivity is not only 
linked to food-related control in a purely experimental framework but is also a prognostic 
biomarker for a real-world outcome parameter of control – dietary success in obesity. 
Furthermore, our findings are well in line with the assumptions of the influential 'impaired 
response inhibition and salience attribution' theory proposed for addiction by e.g. Volkow et al. 
(2010) and Goldstein & Volkow (2002). This theory holds that inhibitory influences of the 
(dorsal) prefrontal cortex on structures computing a value signal (such as the ventral striatum or 
the VMPFC) are reduced in drug addiction due to an insensitivity induced by overstimulation. 
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Following this theory, reduced top-down influence covaries with disinhibition of stimulus driven 
behaviours such as drug craving and thus consumption.  
 
2.3 Impulse control in the dorsolateral prefrontal cortex counteracts post-diet 
weight regain in obesity 
In this study (Weygandt et al., 2015b), we investigated whether control-related brain activity 
measured with fMRI directly after the end of a 12-week very low calorie diet can be considered 
as prognostic biomarker for real-world success in sustained post-diet weight maintenance.  
 As we and others have shown, a variety of methods exist to induce short-time dietary 
success in obese patients (e.g., Weygandt et al., 2013; Shaw et al., 2006; Sheperd, 2003). 
Unfortunately however, a large number of subjects start regaining weight when weight-loss 
treatment ends -  independent of the type of treatment applied e.g. psychological as well as 
pharmacological (e.g., Sjöström et al., 1998; Wadden et al., 1998). Consequently, we continued 
our longitudinal line of research started in Weygandt et al. (2013) and now searched for 
neurobehavioral biomarkers of sustained weight maintenance across a one-year post-diet 
interval. To achieve this goal, we applied the same experimental fMRI delay-discounting 
paradigm in the same pool of subjects as in Weygandt et al. (2013). In particular, we measured 
food-related neurobehavioral impulse control at two time points, i.e. the beginning (‘T0’) and the 
end (‘T12’) of a one-year weight maintenance interval directly following a 12-week diet 
(addressed in Weygandt et al., 2013). At T0, fMRI data of 23 subjects were assessed and fMRI 
data of 19 subjects were assessed at T12. We tested whether activity in DLPFC at T0 and 
whether activity changes in this area across the weight maintenance period (T0 - T12) were 
linked to the degree of success in maintenance (i.e. BMI at T0 - BMI at T12, corrected for 
several covariates-of-no-interest). The same was done for behavioral impulsivity parameters 
Figure 3 depicts the results for behavioral impulse control parameters and their link to the degree 
of success in one-year post diet weight maintenance.  Figure 4 depicts the results for their neural 




Figure 3. Delay discounting, behavioral impulsivity and success in weight maintenance. a) Value of 
delayed meals for each subject at T0 as function of meal magnitude and delay. For each subject, a pair of 
vertically aligned graphs depicts the true value of delayed meals in the upper graph and the value 
predicted by a hyperbolic discounting function (c.f., Mazur, 1987; see below) in the lower graph. 
Numbers at the bottom of a pair depict subject-specific delay times. Left to each row of graphs the 
magnitude of delayed meal options is depicted. The true subjective value in the upper graph was 
computed as the average of run-wise choices (0 = immediate, 1 = delayed) for each combination of meal 
magnitude and delay. Consequently, the true subjective value corresponds to the empirical choice 
probability of the delayed meal option for a given pair of meal magnitude and delay. The predicted 
subjective value for each combination of meal magnitude and delay in the lower graph was computed 
following a hyperbolic discounting function, i.e. subjective value = meal magnitude / (1 + behavioral 
impulsivity kT0 · meal delay). The pairs of graphs are sorted by success in weight maintenance. 
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Specifically, the pair of graphs for the least successful subject is depicted in the upper left, the pair for the 
most successful subject in the lower right. b) Correlation of impulsivity at T0 and weight maintenance. c) 
Correlation of longitudinal impulsivity changes and weight maintenance. d) Stability of food-related 
impulsivity. The figure and its caption are adapted from Weygandt et al. (2015b). 
 
 
Figure 4. DLPFC activity reflecting impulse control and its relation to the degree of weight maintenance. 
a) DLPFC activity in the anatomical standard space of the Montreal Neurological Institute (MNI; 
Tzourio-Mazoyer et al., 2002) brain reflecting impulse control at T0, centered on the peak voxel (MNI: -
39, 53, 10). b) Activity at T0 with information for weight maintenance, centered on the voxel with peak 
information (MNI: 27, 53, 40). c) Correlation of activity at T0 for MNI: 27, 53, 40 and weight 
maintenance. Coronal slices are shown in neurological orientation. The figure and its caption are adapted 
from Weygandt et al. (2015b). 
  
Taken together, the analyses conducted show that control-related DLPFC activity at T0 is 
coupled to success in weight maintenance. Thus, control-related brain activity measured with 
fMRI directly after the end of a 12-week very low calorie diet can be considered as prognostic 




2.4 Investigation of mindfulness meditation practitioners with voxel-based 
morphometry  
In this study, we investigated brain morphological biomarkers of mindfulness meditation (Hölzel 
et al., 2008). Mindfulness meditation is a technique that is characterized by non-evaluative 
observations of the stream of interoceptive sensations and has been shown to improve overall 
well-being in healthy subjects (Brown & Ryan, 2003) but also symptoms in various disorders 
such as MS (Grossmann et al., 2010), pain, depression and anxiety (Grossmann et al., 2003). 
Consequently, identification of brain-derived biomarkers of mindfulness meditation can be 
important for the treatment of neurologic as well as psychiatric disorders. 
To investigate markers of mindfulness meditation, we conducted two analyses. In 
particular, we analyzed differences in local gray matter concentration between a group of 
mindfulness meditation practitioners (n = 20) and non-meditating control subjects (n = 20; 
matched with regard to gender, age, education and handedness) on a voxel-level using two-
sample t-tests in the first analysis. Furthermore, we tested whether we could predict the mean 
gray matter concentration in meditation practitioners in several ROI known to be involved in 
mindfulness meditation on a functional level (Cahn & Polich, 2006) based on the overall 
meditation practice in a second analysis using linear multiple regression. 
The first analysis revealed that meditation practitioners were characterized by greater 
grey matter concentration than non-meditating controls in the right anterior insula, the left 
inferior temporal gyrus and the right hippocampus. Furthermore, the second analysis showed that 
average grey matter concentration in the left inferior temporal cortex could be predicted by the 
hours of meditation practice. Importantly, identification of anterior insula is consistent with 
findings in a similar study investigating differences of cortical thickness between meditation 
practitioners and control subjects (Lazar et al., 2005) and with its involvement in interoceptive 
perception in normal healthy subjects (Critchley et al., 2004). Furthermore, identification of 
hippocampus is consistent with findings showing that this area regulates cortical arousal and 
responsiveness (Newberg & Iversen, 2003). 
To summarize, in this study we were able to identify MRI biomarkers of mindfulness 
meditation, a mental technique that has been proven to improve symptoms in neurologic 
(Grossmann et al., 2010) as well as psychiatric disorders (Grossmann et al., 2003). 
 
2.5 Can we overcome the ‘clinico-radiological paradox’ in multiple sclerosis? 
Inspired by the fact that established lesion-related biomarkers for MS such as the overall number 
and volume are only weakly associated with clinical disability in MS (a fact that is known as 
‘clinico-radiological paradox’; Zivadinov & Leist, 2005; Miki et al., 1999; Filippi et al., 1995), 
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we conducted a study that should clarify the link between locally specific MRI voxel intensity 
alterations and symptom severity in relapsing-remitting MS patients (RRMS; n = 40) assessed in 
several functional domains (Hackmack et al., 2012a). Specifically, we used CCA to determine 
the link between local searchlight voxel intensity patterns and cognitive dysfunction, motor and 
overall disability, and finally disease duration in a LOO CV framework. Cognitive dysfunction 
was assessed by the Paced Auditory Serial Addition Test (PASAT; Cutter et al., 1999), motor 
disability was measured by the Timed 25-Foot Walk Test [TWT; Cutter et al., 1999] and the 9-
Hole Peg Test [9-HPT; Cutter et al., 1999]), and overall disability by the EDSS (Kurtzke, 1983). 
In this study, the searchlight CCA approach was performed based on voxel intensity signals 
sampled from T1- (i.e. magnetization prepared rapid gradient echo) and T2-weighted (i.e. Turbo 
Inversion Recovery Magnitude) MRI  images. 
 As expected, searchlight CCA revealed local MRI voxel intensity variations with 
information for cognitive dysfunction in areas involved in working memory such as posterior 
parietal cortex. Furthermore, also areas in middle cingulate gyrus, inferior temporal lobe, and 
fusiform gyrus contained predictive information for cognitive impairment. In addition, motor 
disability could be predicted in subregions of the cerebellum, thalamus, and primary motor 
cortex as well as in posterior parietal cortex and middle frontal gyrus. For overall disability a 
cluster in the inferior frontal gyrus contained maximal predictive information. Finally, the 
analysis revealed areas in somatosensory cortex and posterior parietal cortex as being predictive 
of disease duration.   
 Taken together, contrary to the traditional procedure linking lesion-related parameters 
aggregated across the whole brain to clinically disability in MS, the searchlight approach 
revealed a variety of regionally specific MRI biomarkers for disability in RRMS that are in good 
accordance with existing knowledge on the functional specialization of these regions (see e.g., 
Dehaene et al., 2004). Together with the predictive accuracy obtained in the LOO CV 
framework, these results suggest that the proposed method might be able to overcome the so-
called clinico-radiological paradox in MS. 
 
2.6 MRI-based diagnostic biomarkers for early onset pediatric multiple 
sclerosis 
A growing body of research addresses neurological (e.g. Bigi & Banwell, 2012; Vargas-Lowy et 
al., 2012), epidemiological (e.g., Renoux et al., 2007; Ruggieri et al., 2004) and diagnostic (e.g., 
Polman et al., 2011; Sadaka et al., 2012) features of pediatric MS (PMS) which is typically 
defined as a variant of MS that occurs with an onset of prior or up to an age of 16 (e.g. Sadaka et 
al., 2012; Renoux et al., 2007). Within this age-dependent definition, a prevalence of 2.2% to 5% 
has been reported for PMS among all MS patients (e.g., Renoux et al., 2007; Ruggieri et al., 
2004). However, despite these efforts it is yet unclear whether the term PMS denotes a single, 
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homogenous disease. For example, a study evaluating the validity of the revised McDonald 
criteria for the diagnosis of PMS (Sadaka et al., 2012) found that these criteria were not well 
suited to predict the development of clinically definite MS after acute demyelination for early 
onset pediatric MS (EOPMS) patients with onset prior to the age of eleven. Moreover, a study 
that compared the characteristics of hyperintense lesions in T2-weighted images between 
EOPMS and late onset pediatric MS (LOPMS) patients found that EOPMS patients had less 
well-defined ovoid lesions (Chabas et al., 2008). Furthermore, EOPMS seems to be associated 
with a different pattern of symptoms on a clinical level. Specifically, Ruggieri et al. (1999) found 
that the predominant pattern for EOPMS patients involved consciousness disturbances, seizures, 
and ataxia as compared to predominant optic nerve involvement in LOPMS and adult onset MS. 
Based on such findings, it was recently questioned whether it might be useful to complement the 
MRI-based diagnostic criteria for EOPMS (Chabas et al., 2008). 
Consequently, we combined model-validation and univariate logistic regression 
techniques based on tissue probability parameters of single voxels to search for novel MRI-based 
diagnostic biomarkers for EOPMS in this study (Weygandt et al., 2015a). EOPMS was defined 
as MS with an onset occurring prior to the age of twelve. In particular, we investigated the 
separability of EOPMS patients (n = 16) vs. LOPMS patients (onset < 16 yrs; n = 17) based on 
tissue probability parameters extracted from areas located in grey and white matter separately. 
Moreover, we also investigated the separability of EOPMS patients vs. HC subjects (n = 15) 
based on these parameters and finally the separability of LOPMS and HC. Patients in the 
LOPMS group and HC subjects were matched to the patients of the EOPMS group with regard to 
gender and the two PMS groups were additionally matched in terms of disease duration, age and 
lesion load (please see Weygandt et al. [2015a] for details regarding the matching procedure).  
Results obtained by the logistic regression analyses searching for diagnostic information 
confirmed existing assumptions on the key role of hyperintense periventricular WM lesions for 
the diagnosis of (P)MS. However, by using the combined regression and model-validation 
approach, we also found novel diagnostic biomarkers for EOPMS in frontal gyri and WM areas 
adjacent to these gyri. Consequently, we were able to differentiate EOPMS from LOPMS as well 
as both PMS groups from HC based on local tissue probability information extracted from GM 
and WM areas in datasets acquired with clinical routine brain MRI sequences in this study. 
Importantly, our results validate existing assumptions on the key role of hyperintense WM 
lesions for MS diagnosis but we also found novel non-lesion related biomarkers for PMS. The 
latter finding suggests that conventional MRI contains a richer set of diagnostically relevant 
features related to MS than is typically assumed. Furthermore, diagnostic classification was 
independent of group differences in gender, disease duration, age, and lesion load, as these 
parameters were balanced. Thus, the MRI biomarkers identified reflect neuropathological 




2.7 Multi-scale classification of disease using structural MRI and wavelet 
transform 
Consistent with the prompt to search for novel MRI biomarkers in MS (Charil et al., 2006) due 
to the only moderate MS-specificity of brain lesions and their only moderate link to clinical 
disability in MS (Zivadinov & Leist, 2005; Miki et al., 1999; Filippi et al., 1995), we tested the 
diagnostic utility of wavelet transformations of raw spatial MRI voxel intensity signals as 
features for an MVPA approach in this study (Hackmack et al., 2012b). In short, similar to 
Fourier Analysis, Wavelet Analysis is a complex mathematical technique for analyzing 
systematic signal alterations of varying frequency (see e.g. Graps [1995] for an overview). The 
latter ability makes both methods a potential candidate for analyzing systematic spatial signal 
variations in structural MRI images on different spatial scales simultaneously. However, because 
Wavelet Analysis is better suited to decompose discontinuous or non-stationary signals than 
Fourier Analysis due the finite character of basis functions evaluated (i.e. the Wavelets), we 
decided to use the former method to analyze spatial MRI signal alterations on multiple spatial 
resolutions. In particular, the spatial extent of these scales ranged from cuboid-shaped areas of 
few mm3 volume on the smallest scale to cuboid-shaped areas covering 12.5% of the field of 
view on the largest. Furthermore, the method was applied separately to a dataset consisting of 
structural MRI data of RRMS patients (n = 41) and HC subjects (n = 26), and a dataset 
consisting of structural MRI data of AD patients (n = 20) and HC subjects (n = 20) taken from 
the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. 
 For each of the two data sets, two different types of features were derived from raw 
spatial MRI voxel intensity signals and thus also two different analyses were conducted for each 
data set. First, Wavelets were used to characterize signal variations across three large (‘global’) 
tissue-dependent ROI (areas containing lesions, areas containing normal-appearing brain tissue, 
and the whole brain) on six different spatial scales for each subject included in each of the two 
data sets separately. On each spatial scale, three-dimensional Wavelet basis functions with 28 
different spatial orientations were used to characterize signal variations across the whole ROI. 
After the fit of each orientation-specific Wavelet basis function was determined, these fit 
parameters (which might roughly be understood as indicators of explained variance), were 
combined to yield a pattern for each ROI, scale, subject, and data set containing 28 features. 
Then, a LOO CV MVPA approach using an SVC algorithm was applied to compute diagnostic 
separability of groups based on these global indicators of signal variation specifically for each 
scale and dataset. In the second analysis, local Wavelet coefficients were determined as 
indicators of local signal variations. As in the global analysis, 28 orientation-specific Wavelet 
basis-functions were used to characterize systematic local signal alterations for each of six 
specific spatial scales in each of the ROI. In the next step, a LOO CV MVPA approach using a 
SVC algorithm was applied to compute diagnostic separability of groups based on local Wavelet 
indicators of signal variation.    
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 For the separation of RRMS and HC based on global signal variations, Wavelet 
coefficients derived from lesioned tissue separated best. Specifically, consistent with lesion load 
only in RRMS and not HC, patients were characterized by more/stronger systematic signal 
variations than HC subjects. For the separation of RRMS and HC based on local wavelet 
coefficients, similar results were obtained. Interestingly, especially for lesioned tissue, 
separability increased together with the spatial scale of Wavelet basis functions across all 
positions in the brain in the local analyses. For the separation of AD and HC, the results were 
less conclusive, i.e. accuracy obtained was lower and separability was less specific for selected 
(i.e. the larger) scales than in separation of RRMS and HC. 
 Taken together, this was the first study that characterized the utility of diagnostic MRI 
biomarkers for MS and AD in terms of the spatial extent of features. Importantly, it showed that 
diagnostically relevant neuropathology induces large-scale structural changes in RRMS e.g., 
such as ventricle widening due to thalamic atrophy (Houtchens et al., 2007).  
 
2.8 Multimodal prediction of conversion to Alzheimer based on incomplete 
biomarkers 
In this study (Ritter et al., 2015), we predicted conversion from normal cognition (NC) or mild 
cognitive impairment (MCI) to AD in individual subjects in a three-year follow-up period after 
baseline using extensive multimodal data taken from the ADNI database. In particular, a set of 
288 features from 10 different domains or modalities respectively was included in the analysis 
taken from 237 subjects that were diagnosed as NC or MCI patients at baseline. For 86 of these 
subjects, the diagnosis changed to AD during the three-year interval, for 151 it did not. Features 
were derived from these modalities: MRI (lesion load, volume and voxel information), Positron 
Emission Tomography, laboratory measurements, medical history, medical symptoms at 
baseline, neurological and physical exams, neuropsychological testing and demography. 
Importantly, we addressed several problems in this study that have to be solved if the 
computer- and MRI-based diagnostic approach proposed should be established as a useful tool in 
a clinical real-world setting for automated diagnosis. Specifically, we first investigated the 
problem of how to deal with missing data. This aspect might be especially important in a highly 
multimodal clinical real-world setting since most likely parameters acquired will vary across 
hospitals, attending physicians, and patients. To address this aspect, we compared the results of 
three different interpolation methods for missing data handling on prognostic accuracy (i.e. a 
method using measures of central tendency, a method using an Expectation-Maximization [EM] 
approach, and a combination). Furthermore, we tested procedures to reduce the impact of 
unbalanced training data (i.e. unequal group sizes of converters and non-converters) on 
prognostic accuracy. Finally, we compared the utility of different feature selection approaches 
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(selection of features by human experts and different automated feature selection methods) on 
accuracy.   
Maximal accuracy in predicting conversion from NC or MCI to AD in a three-year 
interval after baseline across all methods compared was 73% (mean of sensitivity and 
specificity). Furthermore, maximal modality-specific accuracies were obtained based on 
neuropsychological markers and markers derived from both imaging modalities. The best 
individual feature was the Functional Activities Questionnaire (Pfeffer et al., 1982). In addition, 
the results show that methods used for handling of unbalanced training data had a significant 
effect only when using an SVC algorithm for prognosis, i.e. the impact of such methods was 
classifier-specific. Presumably due to the presence of features measured on a continuous but also 
an ordinal level together with the unsuitability of the EM-method to handle ordinal data, the 
combined interpolation method was best suited for missing data handling. Finally, although 
feature selection by human experts achieved highest accuracy among all methods compared, also 
automated features selection methods significantly improved prognostic accuracy compared to 
no feature selection. 
Taken together, the results of the study suggest that a combination of automated missing 
data substitution, automated feature selection and computer-based classification can be used in a 















This habilitation synopsis gives an overview on methodological aspects of the computer-based 
disease prediction approach, its development, the research aims pursued with it, and it describes 
the research articles from this field that I submit for habilitation. In particular, the synopsis starts 
by outlining the basic concept of the approach and by describing the three fundamental 
procedural stages characterizing it, i.e. the feature determination, training and test stages. Then, I 
continued by delineating the development of the approach in terms of three epochs that are 
characterized by the discovery of diagnostic information in MR signals, the first use of statistical 
regression techniques to analyze this information, and the mass use of the approach. Finally, I 
outlined research aims pursued with the approach, i.e. automated diagnosis, refinement of 
diagnostic guidelines, and identification of novel diagnostic biomarkers. In the second part of the 
synopsis, I described the peer-reviewed research articles submitted for habilitation. Across these 
articles or studies respectively, all of the three research aims pursued with the approach were 
addressed. Furthermore, technical challenges connected to the approach were addressed in 
various different fashions. Thus, these studies provide a substantial overview on the 
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